{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05226585",
            "orgStudyIdInfo": {
                "id": "2107024013"
            },
            "organization": {
                "fullName": "University of Arizona",
                "class": "OTHER"
            },
            "briefTitle": "Mechanisms of Change in Cognitive Behavioral Therapy for Insomnia (CBTi)",
            "officialTitle": "Mechanisms of Change in Cognitive Behavioral Therapy for Insomnia (CBTi): A Randomized Controlled Pilot Trial",
            "acronym": "CBTi",
            "therapeuticArea": [
                "Other"
            ],
            "study": "mechanisms-of-change-in-cognitive-behavioral-therapy-for-insomnia-cbti"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-05",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2021-10-21",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-10-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-12-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-09-28",
            "studyFirstSubmitQcDate": "2022-01-25",
            "studyFirstPostDateStruct": {
                "date": "2022-02-07",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-05-06",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-08",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "University of Arizona",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to investigate the mechanisms of change in Cognitive Behavioral Therapy for insomnia (CBTi) in a sample of adults aged 50-65. This study aims to evaluate the pre-post treatment change in sleep, circadian rhythms, biomarkers, cognitive performance, and structural and functional magnetic resonance imaging scans (MRI).",
            "detailedDescription": "Baseline Part 1:\n\n* Online demographic and contact information\n* Schedule Baseline Part 2 with the investigators via online link\n* 1 week of daily sleep diaries\n\nBaseline Part 2:\n\n* Internet-based interview with the investigators to confirm study eligibility requirements\n* Online self-report questionnaires\n* 2 weeks of daily sleep diaries\n* 2 weeks of sleep/wake assessment wearing a watch-like activity monitor (Actiwatch)\n\nObjective Baseline:\n\n* Single-night, diagnostic in-home sleep study, including and the following equipment:\n\n  * Adhesive patch which will adhere to the arm\n  * Sensor belts worn around the chest, fitted with nasal canula, pulse oximeter, and 3 electrodes which will adhere to the back of the neck and behind each ear\n* Next-day appointment:\n\n  * Neuropsychological assessment\n  * Structural and functional magnetic resonance imaging scan (MRI)\n  * Non-invasive blood pressure readings\n  * Low-volume Blood draw (used to obtain genetic biomarkers)\n  * Removal of adhesive patch\n* Next-day evening (2-nights):\n\n  * Consumable capsule\n  * Sensor belt worn around the chest/abdomen Random Assignment: If it is determined the participant is eligible for the study, participants will be randomly assigned to one of the treatment groups (in-person, telehealth or internet delivered) or asked to wait to start treatment.\n\nTreatment Phase I:\n\n* Participants will complete up to 12 weeks of insomnia treatment or wait for treatment (\"waitlist\") 12-Week Post-treatment Part 1:\n* Complete 2 weeks of an online daily sleep diary and actigraphy\n* Complete online self-report questionnaires\n\nObjective 12-Week Post-treatment:\n\n\u2022 Repeat \"Objective Baseline\" outlined above\n\nTreatment Phase II (WLC):\n\n* Treatment will start for participants who had been assigned to the waitlist condition 3-Month Follow-Up:\n* Complete online self-report questionnaires"
        },
        "conditionsModule": {
            "conditions": [
                "Sleep Initiation and Maintenance Disorders"
            ],
            "keywords": [
                "insomnia",
                "insomnia disorder",
                "cognitive behavioral therapy"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "interventionModelDescription": "Three treatment arms and a waitlist control",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "DOUBLE",
                    "maskingDescription": "The participant and outcomes assessor will not be aware of participant study conditions.",
                    "whoMasked": [
                        "PARTICIPANT",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 100,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "In-person CBTi",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "CBTi of variable treatment length will be administered by trained study staff in-person.",
                    "interventionNames": [
                        "Behavioral: In-Person Cognitive Behavioral Therapy for Insomnia"
                    ]
                },
                {
                    "label": "Telehealth CBTi",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "CBTi of variable treatment length will be administered by trained study staff via HIPAA-compliant tele-video conference.",
                    "interventionNames": [
                        "Behavioral: Telehealth Cognitive Behavioral Therapy for Insomnia"
                    ]
                },
                {
                    "label": "Internet CBTi",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Self-paced CBTi of variable treatment length will be administered via Sleep Healthy Using The Internet (SHUTi).",
                    "interventionNames": [
                        "Behavioral: Internet Cognitive Behavioral Therapy for Insomnia"
                    ]
                },
                {
                    "label": "Waitlist Control",
                    "type": "NO_INTERVENTION",
                    "description": "Treatment will be postponed by 12 weeks."
                }
            ],
            "interventions": [
                {
                    "type": "BEHAVIORAL",
                    "name": "In-Person Cognitive Behavioral Therapy for Insomnia",
                    "description": "Cognitive behavioral therapy is recommended as a first-line treatment for insomnia (CBTi). CBTi contains the following well-validated components of cognitive behavioral treatment for insomnia: stimulus control, sleep compression, sleep hygiene, relaxation training, and cognitive restructuring.",
                    "armGroupLabels": [
                        "In-person CBTi"
                    ],
                    "otherNames": [
                        "CBTi"
                    ]
                },
                {
                    "type": "BEHAVIORAL",
                    "name": "Telehealth Cognitive Behavioral Therapy for Insomnia",
                    "description": "Telehealth cognitive behavioral therapy is recommended as a first-line treatment for insomnia (CBTi) conducted via audio-video communication. tCBTi contains the following well-validated components of cognitive-behavioral treatment for insomnia: stimulus control, sleep compression, sleep hygiene, relaxation training, and cognitive restructuring.",
                    "armGroupLabels": [
                        "Telehealth CBTi"
                    ],
                    "otherNames": [
                        "tCBTi"
                    ]
                },
                {
                    "type": "BEHAVIORAL",
                    "name": "Internet Cognitive Behavioral Therapy for Insomnia",
                    "description": "Sleep Healthy Using The Internet (SHUTi; aka iCBTi) is a self-guided, fully automated, online CBTi program that includes interactive features: personalized goal setting, graphical feedback based on inputted data, animations/illustrations to enhance comprehension, patient vignettes, and video-based expert explanations.",
                    "armGroupLabels": [
                        "Internet CBTi"
                    ],
                    "otherNames": [
                        "iCBTi"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Insomnia Severity Index",
                    "description": "Self-reported severity of insomnia symptoms is assessed once at baseline.",
                    "timeFrame": "Pre-treatment"
                },
                {
                    "measure": "Insomnia Severity Index",
                    "description": "Self-reported severity of insomnia symptoms is assessed weekly through the duration of treatment.",
                    "timeFrame": "During treatment"
                },
                {
                    "measure": "Insomnia Severity Index",
                    "description": "Self-reported severity of insomnia symptoms is assessed once at posttreatment.",
                    "timeFrame": "12-week Post-treatment"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Diary-assessed Sleep",
                    "description": "Self-reported severity of sleep parameters (e.g., sleep efficiency, total sleep time, total time in bed).",
                    "timeFrame": "Pre-treatment"
                },
                {
                    "measure": "Diary-assessed Sleep",
                    "description": "Self-reported severity of sleep parameters (e.g., sleep efficiency, total sleep time, total time in bed).",
                    "timeFrame": "During treatment"
                },
                {
                    "measure": "Diary-assessed Sleep",
                    "description": "Self-reported severity of sleep parameters (e.g., sleep efficiency, total sleep time, total time in bed).",
                    "timeFrame": "12 week Post-treatment"
                }
            ],
            "otherOutcomes": [
                {
                    "measure": "Circadian Rhythm",
                    "description": "Circadian rhythms as assessed by core body temperature",
                    "timeFrame": "Pre-treatment"
                },
                {
                    "measure": "Circadian Rhythm",
                    "description": "Circadian rhythms as assessed by core body temperature",
                    "timeFrame": "12 week Post-treatment"
                },
                {
                    "measure": "Magnetic resonance imaging (MRI)",
                    "description": "Neurological outcomes (e.g., MRI resting-state functional connectivity: cingulate cortex, left insula, left cuneus, and fusiform; salience, executive control, and default mode networks.)",
                    "timeFrame": "Pre-treatment"
                },
                {
                    "measure": "Magnetic resonance imaging (MRI)",
                    "description": "Neurological outcomes (e.g., MRI resting-state functional connectivity: cingulate cortex, left insula, left cuneus, and fusiform; salience, executive control, and default mode networks.)",
                    "timeFrame": "12 week Post-treatment"
                },
                {
                    "measure": "Inflammatory Health",
                    "description": "Cytokines (e.g., IL-6, IL-10, TNFalpha, GFAP, Tau, NFL, UCHL1)",
                    "timeFrame": "12 week Pre-treatment"
                },
                {
                    "measure": "Inflammatory Health",
                    "description": "Cytokines (e.g., IL-6, IL-10, TNFalpha, GFAP, Tau, NFL, UCHL1)",
                    "timeFrame": "12 week Post-treatment"
                },
                {
                    "measure": "Evaluation of executive functioning",
                    "description": "Neuropsychological tests of executive functioning using a program administered via iPad",
                    "timeFrame": "Pre-treatment"
                },
                {
                    "measure": "Evaluation of episodic memory",
                    "description": "Neuropsychological tests of episodic memory using a program administered via iPad",
                    "timeFrame": "Pre-treatment"
                },
                {
                    "measure": "Evaluation of executive functioning",
                    "description": "Neuropsychological tests of executive functioning using a program administered via iPad. Due to the nature of these assessments, specific details of the tests cannot be disclosed.",
                    "timeFrame": "12 week Post-treatment"
                },
                {
                    "measure": "Evaluation of episodic memory",
                    "description": "Neuropsychological tests of episodic memory using a program administered via iPad. Due to the nature of these assessments, specific details of the tests cannot be disclosed.",
                    "timeFrame": "12 week Post-treatment"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Aged 50-65\n* Normal hearing with or without hearing aids\n* Ability to speak and read English and ability to give informed consent\n* Possession of a computer with video and audio capabilities\n* Meets DSM-5 Criteria for Insomnia Disorder\n* Internet speed sufficient for participating in teletherapy (e.g., Zoom Health) or SHUTi (for iCBTi group)\n* MoCA scores \u226524 will be deemed normal cognitive status and considered eligible for study participation and/or assessed by the ability to comprehend the baseline screening questionnaires\n* Willing to refrain from new external behavioral health or medication treatment for issues pertaining to sleep during participation in the study\n* Indication that the individual plans to be in the area for the 6 months following the first baseline assessment\n\nExclusion Criteria:\n\n* Failure to meet the above \"inclusion criteria\"\n* Current circadian rhythm disorder, sleep deprivation, or hypersomnia and related sleep disorders (assessed with clinical interview and/or self-report) as CBTi has not been validated in these populations. Verified by self-report and/or clinical interview (SCISD-R)\n* Untreated sleep disordered breathing (e.g., obstructive sleep apnea) assessed by self-report, clinical interview, and/or diagnostic sleep study (i.e., baseline sleep study PSG)\n* Failing to meet criteria for MRI scan (e.g., having metallic implants); see Pre-screen MRI Checklist for full list of exclusions for MRI scans.\n* Fear/phobia of needles (conflict with blood draw) and/or small spaces (conflict with MRI scanner)\n* Current suicide risk meriting crisis intervention as assessed by the Patient Health Questionnaire (PHQ-9) and/or disclosure of serious suicidal ideation\n* Pregnancy (self-report, proposed instruments and treatments have not been validated in this population)\n* Sleep efficiency \\> 85%, assessed by the sleep diary\n* Serious mental health diagnosis (e.g., bipolar disorder or psychosis) assessed by structured interview (M.I.N.I.)\n* Currently engaged in evidence-based psychotherapy for Insomnia (i.e., Cognitive Behavioral Therapy) by self-report\n* Failure to follow protocol (e.g., consistent \"no show\" for appointments, answering questionnaires dishonestly, refusal to complete more than 2 assessments \\[e.g., fMRI and Neuropsych\\])",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "50 Years",
            "maximumAge": "65 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Ethan Olson",
                    "role": "CONTACT",
                    "phone": "520-621-8366",
                    "email": "ethanadamolson@arizona.edu"
                },
                {
                    "name": "Alisa Huskey, Ph.D.",
                    "role": "CONTACT",
                    "phone": "520-621-8366",
                    "email": "ahuskey@arizona.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Daniel J Taylor, Ph.D.",
                    "affiliation": "The University of Arizona",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "The University of Arizona",
                    "status": "RECRUITING",
                    "city": "Tucson",
                    "state": "Arizona",
                    "zip": "85721",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Ethan Olson",
                            "role": "CONTACT",
                            "phone": "520-621-8366",
                            "email": "ethanadamolson@email.arizona.edu"
                        },
                        {
                            "name": "Alisa M Huskey, Ph.D.",
                            "role": "CONTACT",
                            "phone": "520-621-8366",
                            "email": "ahuskey@email.arizona.edu"
                        },
                        {
                            "name": "Daniel J Taylor, Ph.D.",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.22174,
                        "lon": -110.92648
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000007319",
                    "term": "Sleep Initiation and Maintenance Disorders"
                }
            ],
            "ancestors": [
                {
                    "id": "D000020919",
                    "term": "Sleep Disorders, Intrinsic"
                },
                {
                    "id": "D000020920",
                    "term": "Dyssomnias"
                },
                {
                    "id": "D000012893",
                    "term": "Sleep Wake Disorders"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                },
                {
                    "id": "D000001523",
                    "term": "Mental Disorders"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M10356",
                    "name": "Sleep Initiation and Maintenance Disorders",
                    "asFound": "Sleep Initiation and Maintenance Disorders",
                    "relevance": "HIGH"
                },
                {
                    "id": "M22242",
                    "name": "Parasomnias",
                    "relevance": "LOW"
                },
                {
                    "id": "M22654",
                    "name": "Sleep Disorders, Intrinsic",
                    "relevance": "LOW"
                },
                {
                    "id": "M22655",
                    "name": "Dyssomnias",
                    "relevance": "LOW"
                },
                {
                    "id": "M15696",
                    "name": "Sleep Wake Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M4815",
                    "name": "Mental Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M14473",
                    "name": "Psychotic Disorders",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "BXM",
                    "name": "Behaviors and Mental Disorders"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                }
            ]
        }
    },
    "hasResults": false
}